{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:49:38Z","timestamp":1790394578217,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejim.2025.04.009","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T23:28:21Z","timestamp":1744759701000},"page":"4-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A physico-chemical explanation for the litho-protective effects of obeticholic acid in low phospholipid-associated cholelithiasis"],"prefix":"10.1016","volume":"137","author":[{"given":"Karel J.","family":"van Erpecum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Portincasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard P.","family":"van Berge Henegouwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Moschetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2025.04.009_bib0001","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1136\/gutjnl-2022-327955","article-title":"Consensus definition of sludge and microlithiasis as a possible cause of pancreatitis","volume":"72","author":"\u017borniak","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2025.04.009_bib0002","article-title":"Gallstones","volume":"2","author":"Lammert","year":"2016","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.ejim.2025.04.009_bib0003","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s11739-023-03355-z","article-title":"Metabolic dysfunction-associated gallstone disease: expecting more from critical care manifestations","volume":"18","author":"Portincasa","year":"2023","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.ejim.2025.04.009_bib0004","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1111\/liv.14662","article-title":"Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma","volume":"40","author":"de Vries","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2025.04.009_bib0005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/apt.17761","article-title":"Obeticholic acid as a second-line treatment for low phospholipid-associated cholelithiasis syndrome","volume":"59","author":"Soret","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2025.04.009_bib0006","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jhep.2019.06.011","article-title":"Obeticholic acid may increase the risk of gallstone formation in susceptible patients","volume":"71","author":"Al-Dury","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2025.04.009_bib0007","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2025.04.009_bib0008","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/S0022-2275(20)37458-7","article-title":"Characterization of crystallization pathways during cholesterol precipitation from human gallbladder biles: identical pathways to corresponding model biles with three predominating sequences","volume":"37","author":"Wang","year":"1996","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ejim.2025.04.009_bib0009","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0022-2275(20)37700-2","article-title":"Molecular species composition of inter-mixed micellar\/vesicular bile salt concentrations in model bile: dependence upon hydrophilic-hydrophobic balance","volume":"34","author":"Donovan","year":"1993","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ejim.2025.04.009_bib0010","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0022-2275(20)32033-2","article-title":"Sphingomyelin exhibits greatly enhanced protection compared with egg yolk phosphatidylcholine against detergent bile salts","volume":"41","author":"Moschetta","year":"2000","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ejim.2025.04.009_bib0011","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0005-2760(97)00002-7","article-title":"MC Carey Influence of bile salts on molecular interactions between sphingomyelin and cholesterol: relevance to bile formation and stability","volume":"1345","author":"Van Erpecum","year":"1997","journal-title":"Biochim Biophys Acta - Lipid Lipid Metab"},{"key":"10.1016\/j.ejim.2025.04.009_bib0012","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1194\/jlr.M500178-JLR200","article-title":"A phylogenetic survey of biliary lipids in vertebrates","volume":"46","author":"Moschetta","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ejim.2025.04.009_bib0013","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0022-2275(20)37603-3","article-title":"Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physical-chemical variables of pathophysiologic relevance and identification of a stable liquid crystalline state in cold, dilute and hydrophilic","volume":"37","author":"Wang","year":"1996","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ejim.2025.04.009_bib0014","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0168-8278(01)00173-8","article-title":"Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: soluble pronucleating proteins in gallbladder and hepatic biles","volume":"35","author":"Van Erpecum","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2025.04.009_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840110102","article-title":"Bile concentration is a key factor for nucleation of cholesterol crystals and cholesterol saturation index in gallbladder bile of gallstone patients","volume":"11","author":"Van Erpecum","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2025.04.009_bib0016","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2025.04.009_bib0017","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/nm1138","article-title":"Prevention of cholesterol gallstone disease by FXR agonists in a mouse model","volume":"10","author":"Moschetta","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.ejim.2025.04.009_bib0018","doi-asserted-by":"crossref","first-page":"9201","DOI":"10.1021\/acs.jmedchem.6b01126","article-title":"Discovery of 3\u03b1,7\u03b1,11\u03b2-Trihydroxy-6\u03b1-ethyl-5\u03b2-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders","volume":"59","author":"Pellicciari","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.ejim.2025.04.009_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113380","article-title":"Farnesoid X receptor activation by the novel agonist TC-100 (3\u03b1, 7\u03b1, 11\u03b2-Trihydroxy-6\u03b1-ethyl-5\u03b2-cholan-24-oic Acid) preserves the intestinal barrier integrity and promotes intestinal microbial reshaping in a mouse model of obstructed bile acid flow","volume":"153","author":"Marzano","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ejim.2025.04.009_bib0020","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nm1501","article-title":"Identification of a hormonal basis for gallbladder filling","volume":"12","author":"Choi","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ejim.2025.04.009_bib0021","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/hep.20022","article-title":"Spontaneous cholecysto- and hepatolithiasis in Mdr2-\/- mice: a model for low phospholipid-associated cholelithiasis","volume":"39","author":"Lammert","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2025.04.009_bib0022","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1053\/gast.2001.23947","article-title":"MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis","volume":"120","author":"Rosmorduc","year":"2001","journal-title":"Gastroenterology"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525001396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525001396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T17:29:43Z","timestamp":1753723783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620525001396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":22,"alternative-id":["S0953620525001396"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.04.009","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A physico-chemical explanation for the litho-protective effects of obeticholic acid in low phospholipid-associated cholelithiasis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}